Results 101 to 110 of about 42,857 (235)
Real‐world Validation of the MAGIC‐D Index. The MAGIC‐D index was validated using real‐world data from patients with unresectable BTC who received durvalumab‐chemotherapy at Tongji Hospital. The risk stratification ability of the MAGIC‐D index for patient survival was improved after incorporating Ki67 and CA 19‐9.
Tianao Zhan +9 more
wiley +1 more source
Antioxidant vitamins and hyperbilirubinemia in neonates
Objective: Low antioxidant system may contribute to the severity of neonatal hyperbilirubinemia. The aim of this research was to explore the relationship between plasma vitamin E and C levels and the severity of hyperbilirubinemia in full-term neonates ...
Obediat, Ahmad D. +3 more
doaj
Background: Genetic variants of UGT1A1, involved in glucuronidation and clearance of bilirubin, are associated with reduced bilirubin metabolization and drug-induced isolated hyperbilirubinemia. We studied the impact of the UGT1A1*28 polymorphism on drug-
Nissen, Peter Henrik +13 more
core +1 more source
Hyperbilirubinemia (total bilirubin >2 mg/dL) during the treatment.
Hyperbilirubinemia (total bilirubin >2 mg/dL) during the treatment.
Dar-In Tai (44644) +9 more
core +1 more source
ABSTRACT Hepatic AL amyloidosis can cause severe cholestasis independent of marrow tumor burden. In patients with absolute contraindications to high‐dose steroids—such as steroid‐induced psychosis—tailored daratumumab regimens with low‐dose corticosteroids can drive rapid, life‐saving organ reversal.
R. Ceccarelli +8 more
wiley +1 more source
ABSTRACT Severe Plasmodium vivax malaria may cause vasopressor‐requiring shock, profound thrombocytopenia, jaundice, coagulation activation, and transient cardiopulmonary abnormalities. Early parasite confirmation and close monitoring for evolving organ dysfunction are essential.
Bushra Majid +8 more
wiley +1 more source
Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart +6 more
wiley +1 more source
Abstract Clinical pharmacokinetic drug–drug interaction (PK‐DDI) studies are frequently required in drug development when metabolizing enzymes and transporters determine pharmacokinetics. Drugs can be victims, perpetrators, or victims and perpetrators, of PK‐DDIs, so the clinical consequences of these interactions, particularly the risks of severe ...
Thomas M. Polasek, John O. Miners
wiley +1 more source
Background Severe neonatal hyperbilirubinemia could lead to kernicterus and neonatal death. This study aimed to analyze the association between single nucleotide polymorphisms in genes involved in bilirubin metabolism and the incidence of severe ...
Juan Fan +7 more
doaj +1 more source
Profile of infants admitted for significant neonatal hyperbilirubinemia.
Profile of infants admitted for significant neonatal hyperbilirubinemia.
Bolajoko O. Olusanya (692132) +3 more
core +1 more source

